StockFacets
About
Sign-up
Sign-in
Earnings Calendar
Prices are updated after-hours
Published
Previous years
100
Publishing Date
2023 - 07 - 11
3
2023 - 05 - 02
2
2023 - 03 - 20
2
2023 - 01 - 06
1
2023 - 01 - 04
1
2022 - 12 - 20
1
2022 - 12 - 16
1
2022 - 12 - 15
2
2022 - 12 - 14
1
2022 - 12 - 08
1
2022 - 12 - 07
2
2022 - 12 - 06
1
2022 - 11 - 28
2
2022 - 11 - 14
2
2022 - 11 - 07
1
2022 - 11 - 03
1
2022 - 10 - 26
1
2022 - 10 - 24
1
2022 - 10 - 20
1
2022 - 10 - 11
1
2022 - 09 - 26
1
2022 - 09 - 23
1
2022 - 09 - 21
1
2022 - 09 - 16
1
2022 - 08 - 24
1
2022 - 08 - 22
1
2022 - 08 - 03
1
2022 - 08 - 01
1
2022 - 07 - 27
1
2022 - 07 - 26
1
2022 - 07 - 22
1
2022 - 07 - 12
2
2022 - 07 - 11
1
2022 - 07 - 06
1
2022 - 07 - 04
1
2022 - 06 - 30
1
2022 - 06 - 29
1
2022 - 06 - 23
1
2022 - 06 - 21
1
2022 - 06 - 15
1
2022 - 06 - 13
2
2022 - 06 - 10
1
2022 - 06 - 06
1
2022 - 06 - 03
1
2022 - 05 - 26
1
2022 - 05 - 20
1
2022 - 05 - 19
1
2022 - 05 - 18
1
2022 - 05 - 17
1
2022 - 05 - 12
2
2022 - 04 - 21
1
2022 - 04 - 20
1
2022 - 04 - 12
1
2022 - 03 - 30
1
2022 - 03 - 28
1
2022 - 03 - 25
2
2021 - 11 - 06
1
2021 - 10 - 02
1
2021 - 06 - 20
1
2014 - 09 - 30
1
Sector
Commercial services
2
Communications
1
Consumer non-durables
2
Electronic technology
3
Energy minerals
1
Finance
1
Finance and insurance
2
Health services
2
Health technology
67
Manufacturing
5
Mining, quarrying, and oil and gas extraction
3
N/a
2
Non-energy minerals
3
Professional, scientific, and technical services
3
Technology services
1
Tags
Acquisition
136
Agreement
127
Application
49
Biopharma
68
Business
110
Cancer
95
Ceo
72
Collaboration
54
Commercial
48
Conference
628
Corporation
120
Day
59
Deadline
211
Disease
87
Drug
63
Earnings
164
Energy
155
Events
157
Fda
94
Financial
549
Genetown
56
Global
213
Group
141
Growth
176
Health
124
International
86
Life
48
Management
68
Market
314
Media
50
Medical
48
Meeting
117
N/a
6257
Nasdaq
83
Offering
80
Partnership
63
People
62
Pharm-country
58
Pharma
81
Pharmaceuticals
114
Phase 2
51
Platform
68
Positive
100
Potential
55
Presentation
74
Program
130
Report
348
Research
237
Results
1028
Sciences
54
Services
89
Solutions
91
Study
102
System
68
Technology
136
Therapeutics
411
Treatment
128
Trial
175
Update
213
Year
223
Entities
89bio, inc.
1
9 meters biopharma, inc.
1
Abeona therapeutics inc.
1
Ac immune sa
1
Acasti pharma, inc.
1
Acorn energy, inc.
1
Aeon biopharma, inc.
1
Aeterna zentaris inc.
1
Alcon inc.
1
Alimera sciences, inc.
1
Alphabet inc.
1
Altimmune, inc.
1
Amgen inc.
1
Apple inc.
1
Aquestive therapeutics, inc.
4
Arcutis biotherapeutics, inc.
1
Arrival
1
Arvinas, inc.
1
Astria therapeutics, inc.
1
Avidity biosciences, inc.
1
Avrobio, inc.
1
Bank of montreal
1
Beigene, ltd.
1
Better therapeutics inc
1
Biontech se
1
Bridgebio pharma, inc.
1
Bristol-myers squibb company
2
Broadcom inc.
1
Catalyst pharmaceuticals, inc.
1
China petroleum & chemical corp
1
China petroleum & chemical corporation
1
Clearside biomedical, inc.
2
Cogent biosciences, inc.
1
Colgate-palmolive company
1
Coya therapeutics, inc.
1
Curevac n.v.
2
Dare bioscience, inc.
2
Editas medicine, inc.
1
Eli lilly and company
1
Energy fuels inc
1
Enlivex therapeutics ltd.
1
Exxon mobil corporation
1
Eyenovia, inc.
1
Fennec pharmaceuticals inc.
1
Forte biosciences, inc.
1
Fortress biotech, inc.
2
Fpx nickel corp.
1
Glaxosmithkline plc
2
Grifols, s.a.
1
Horizon therapeutics public limited company
1
Immutep limited
2
Incannex healthcare ltd
1
Incyte corporation
1
Journey medical corp
2
Novartis ag
2
Pfizer, inc.
2
Sanofi
2
Silo pharma, inc.
2
Windtree therapeutics, inc.
2
Xortx therapeutics inc.
2
Symbols
AAPL
1
ABEO
1
ACFN
1
ACIU
1
ACST
1
AEON
1
AEZS
1
ALC
1
ALIM
1
ALT
1
AMGN
1
AQST
4
ARQT
1
ARVL
1
ARVN
1
ATXS
1
AVGO
1
AVRO
1
BBIO
1
BGNE
1
BMO
1
BMY
2
BNTX
1
BTTX
1
CL
1
CLSD
2
COGT
1
COYA
1
CPRX
1
CVAC
2
DARE
2
DERM
2
DGX
1
EDIT
1
ENLV
1
ETNB
1
EYEN
1
FBIO
2
FBRX
1
FENC
1
FNCTF
1
FPOCF
1
GLAXF
2
GOOG
1
GOOGL
1
GRFS
1
GSK
2
HZNP
1
IMMP
2
INCY
1
IONS
1
IXHL
1
NVS
2
NVSEF
2
PFE
2
SILO
2
SNY
2
SNYNF
2
WINT
2
XRTX
2
Exchanges
Amex
2
Nasdaq
92
Nyse
14
Crawled Date
2023 - 07 - 11
3
2023 - 05 - 02
2
2023 - 03 - 20
2
2023 - 01 - 06
1
2023 - 01 - 04
1
2022 - 12 - 20
1
2022 - 12 - 16
1
2022 - 12 - 15
2
2022 - 12 - 14
1
2022 - 12 - 08
1
2022 - 12 - 07
2
2022 - 12 - 06
1
2022 - 11 - 28
2
2022 - 11 - 14
2
2022 - 11 - 07
1
2022 - 11 - 03
1
2022 - 10 - 26
1
2022 - 10 - 24
1
2022 - 10 - 20
1
2022 - 10 - 11
1
2022 - 09 - 26
1
2022 - 09 - 23
1
2022 - 09 - 21
1
2022 - 09 - 16
1
2022 - 08 - 24
1
2022 - 08 - 22
1
2022 - 08 - 03
1
2022 - 08 - 01
1
2022 - 07 - 27
1
2022 - 07 - 26
1
2022 - 07 - 22
1
2022 - 07 - 12
2
2022 - 07 - 11
1
2022 - 07 - 06
1
2022 - 07 - 04
1
2022 - 06 - 30
1
2022 - 06 - 29
1
2022 - 06 - 23
1
2022 - 06 - 21
1
2022 - 06 - 15
1
2022 - 06 - 13
2
2022 - 06 - 10
1
2022 - 06 - 06
1
2022 - 06 - 03
1
2022 - 05 - 26
1
2022 - 05 - 20
1
2022 - 05 - 19
1
2022 - 05 - 18
1
2022 - 05 - 17
1
2022 - 05 - 12
2
2022 - 04 - 21
1
2022 - 04 - 20
1
2022 - 04 - 12
1
2022 - 03 - 30
1
2022 - 03 - 28
1
2022 - 03 - 25
2
2021 - 11 - 06
1
2021 - 10 - 02
1
2021 - 06 - 20
1
2021 - 03 - 21
1
Crawled Time
00:00
49
00:20
10
01:00
25
02:00
14
03:00
7
04:00
6
04:20
2
05:00
15
06:00
32
07:00
46
08:00
40
08:20
7
09:00
38
10:00
35
11:00
223
11:01
3
11:03
2
12:00
464
12:01
5
12:03
8
12:04
2
12:07
2
12:15
41
12:20
100
12:30
65
12:58
2
13:00
312
13:01
5
13:02
3
13:05
2
13:07
2
13:14
2
13:15
30
13:20
65
13:30
67
13:35
2
14:00
200
14:01
9
14:15
20
14:20
34
14:30
37
15:00
117
15:15
7
15:20
14
15:30
30
16:00
69
16:01
3
16:20
35
17:00
94
18:00
67
19:00
50
20:00
97
20:20
22
21:00
117
21:06
5
22:00
114
22:01
3
22:12
3
22:13
5
23:00
80
Source
mindmed.co
1
neurosense.investorroom.com
1
www.aquestive.com
3
www.biospace.com
34
www.curevac.com
2
www.fpxnickel.com
1
www.globenewswire.com
45
www.prnewswire.com
13
Sort by:
after hours % change
|
delayed % change
|
gain open
|
gain high
|
gain close
|
publishing date
(GMT-12:00) International Date Line West
(GMT-11:00) American Samoa
(GMT-11:00) Midway Island
(GMT-10:00) Hawaii
(GMT-09:00) Alaska
(GMT-08:00) Pacific Time (US & Canada)
(GMT-08:00) Tijuana
(GMT-07:00) Arizona
(GMT-07:00) Chihuahua
(GMT-07:00) Mazatlan
(GMT-07:00) Mountain Time (US & Canada)
(GMT-06:00) Central America
(GMT-06:00) Central Time (US & Canada)
(GMT-06:00) Guadalajara
(GMT-06:00) Mexico City
(GMT-06:00) Monterrey
(GMT-06:00) Saskatchewan
(GMT-05:00) Bogota
(GMT-05:00) Eastern Time (US & Canada)
(GMT-05:00) Indiana (East)
(GMT-05:00) Lima
(GMT-05:00) Quito
(GMT-04:00) Atlantic Time (Canada)
(GMT-04:00) Caracas
(GMT-04:00) Georgetown
(GMT-04:00) La Paz
(GMT-04:00) Puerto Rico
(GMT-04:00) Santiago
(GMT-03:30) Newfoundland
(GMT-03:00) Brasilia
(GMT-03:00) Buenos Aires
(GMT-03:00) Greenland
(GMT-03:00) Montevideo
(GMT-02:00) Mid-Atlantic
(GMT-01:00) Azores
(GMT-01:00) Cape Verde Is.
(GMT+00:00) Casablanca
(GMT+00:00) Dublin
(GMT+00:00) Edinburgh
(GMT+00:00) Lisbon
(GMT+00:00) London
(GMT+00:00) Monrovia
(GMT+00:00) UTC
(GMT+01:00) Amsterdam
(GMT+01:00) Belgrade
(GMT+01:00) Berlin
(GMT+01:00) Bern
(GMT+01:00) Bratislava
(GMT+01:00) Brussels
(GMT+01:00) Budapest
(GMT+01:00) Copenhagen
(GMT+01:00) Ljubljana
(GMT+01:00) Madrid
(GMT+01:00) Paris
(GMT+01:00) Prague
(GMT+01:00) Rome
(GMT+01:00) Sarajevo
(GMT+01:00) Skopje
(GMT+01:00) Stockholm
(GMT+01:00) Vienna
(GMT+01:00) Warsaw
(GMT+01:00) West Central Africa
(GMT+01:00) Zagreb
(GMT+01:00) Zurich
(GMT+02:00) Athens
(GMT+02:00) Bucharest
(GMT+02:00) Cairo
(GMT+02:00) Harare
(GMT+02:00) Helsinki
(GMT+02:00) Jerusalem
(GMT+02:00) Kaliningrad
(GMT+02:00) Kyiv
(GMT+02:00) Pretoria
(GMT+02:00) Riga
(GMT+02:00) Sofia
(GMT+02:00) Tallinn
(GMT+02:00) Vilnius
(GMT+03:00) Baghdad
(GMT+03:00) Istanbul
(GMT+03:00) Kuwait
(GMT+03:00) Minsk
(GMT+03:00) Moscow
(GMT+03:00) Nairobi
(GMT+03:00) Riyadh
(GMT+03:00) St. Petersburg
(GMT+03:30) Tehran
(GMT+04:00) Abu Dhabi
(GMT+04:00) Baku
(GMT+04:00) Muscat
(GMT+04:00) Samara
(GMT+04:00) Tbilisi
(GMT+04:00) Volgograd
(GMT+04:00) Yerevan
(GMT+04:30) Kabul
(GMT+05:00) Ekaterinburg
(GMT+05:00) Islamabad
(GMT+05:00) Karachi
(GMT+05:00) Tashkent
(GMT+05:30) Chennai
(GMT+05:30) Kolkata
(GMT+05:30) Mumbai
(GMT+05:30) New Delhi
(GMT+05:30) Sri Jayawardenepura
(GMT+05:45) Kathmandu
(GMT+06:00) Almaty
(GMT+06:00) Astana
(GMT+06:00) Dhaka
(GMT+06:00) Urumqi
(GMT+06:30) Rangoon
(GMT+07:00) Bangkok
(GMT+07:00) Hanoi
(GMT+07:00) Jakarta
(GMT+07:00) Krasnoyarsk
(GMT+07:00) Novosibirsk
(GMT+08:00) Beijing
(GMT+08:00) Chongqing
(GMT+08:00) Hong Kong
(GMT+08:00) Irkutsk
(GMT+08:00) Kuala Lumpur
(GMT+08:00) Perth
(GMT+08:00) Singapore
(GMT+08:00) Taipei
(GMT+08:00) Ulaanbaatar
(GMT+09:00) Osaka
(GMT+09:00) Sapporo
(GMT+09:00) Seoul
(GMT+09:00) Tokyo
(GMT+09:00) Yakutsk
(GMT+09:30) Adelaide
(GMT+09:30) Darwin
(GMT+10:00) Brisbane
(GMT+10:00) Canberra
(GMT+10:00) Guam
(GMT+10:00) Hobart
(GMT+10:00) Melbourne
(GMT+10:00) Port Moresby
(GMT+10:00) Sydney
(GMT+10:00) Vladivostok
(GMT+11:00) Magadan
(GMT+11:00) New Caledonia
(GMT+11:00) Solomon Is.
(GMT+11:00) Srednekolymsk
(GMT+12:00) Auckland
(GMT+12:00) Fiji
(GMT+12:00) Kamchatka
(GMT+12:00) Marshall Is.
(GMT+12:00) Wellington
(GMT+12:45) Chatham Is.
(GMT+13:00) Nuku'alofa
(GMT+13:00) Samoa
(GMT+13:00) Tokelau Is.
tags :
Positive
crawled time :
12:20
save search
Potential of Arvinas’ PROTAC® AR Degraders Reinforced by 11.1 months rPFS with Bavdegalutamide and Updated Positive Interim Data from Second Generation ARV-766 in mCRPC
Published:
2023-10-22
(Crawled : 12:20)
- globenewswire.com
ARVN
|
$34.78
1.43%
1.41%
940K
|
Health Technology
|
Email alert
Add to watchlist
arv-766
protac
positive
potential
Avidity Biosciences Announces New Positive AOC 1001 Data Demonstrating Improvement in Multiple Additional Functional Endpoints and Favorable Long-term Safety and Tolerability in People with Myotonic Dystrophy Type 1
Published:
2023-10-07
(Crawled : 12:20)
- prnewswire.com
RNA
|
$22.74
-1.3%
-1.32%
1M
|
Health Technology
|
Email alert
Add to watchlist
favorable
positive
BridgeBio presents detailed positive results from Phase 3 ATTRibute-CM study of acoramidis for patients with transthyretin amyloid cardiomyopathy (ATTR-CM) at European Society of Cardiology Congress 2023
Published:
2023-08-27
(Crawled : 12:20)
- globenewswire.com
BBIO
|
$24.74
-0.84%
-0.85%
2M
|
Health Technology
|
Email alert
Add to watchlist
positive
cardiology
results
study
LM Funding America, Inc. Achieves Over 1,260% Year-Over-Year Revenue Growth to $3.2 Million and Generates Positive Core EBITDA for the Second Quarter of 2023
Published:
2023-08-14
(Crawled : 12:20)
- globenewswire.com
LMFA
|
$2.79
4.49%
4.3%
70K
|
Commercial Services
|
251.62%
|
O:
2.03%
H:
0.0%
C:
-13.36%
positive
funding
growth
Acorn Achieves Net Income and Positive Cash Flow as Q2 Revenue Rises 22% from Remote Monitoring and Control Solutions for Backup Generators and Gas Pipelines
Published:
2023-08-10
(Crawled : 12:20)
- globenewswire.com
ACFN
|
$7.0
-95.92%
190
|
Professional, Scientific, and T...
|
2166.67%
|
O:
3.33%
H:
17.9%
C:
12.9%
control
positive
gas
solutions
flow
Silo Pharma Reaches Positive Milestone with Nasal Formulation of SPC-15 For Anxiety, PTSD, and Stress-Related Disorders
Published:
2023-08-08
(Crawled : 12:20)
- globenewswire.com
SILO
|
$1.97
0.0%
40K
|
Finance and Insurance
|
-12.05%
|
O:
11.61%
H:
22.0%
C:
-8.0%
spc-15
pharma
positive
disorders
milestone
spc-14
Yield10 Bioscience Announces Positive Results in the First Field Test of Stacked Herbicide Tolerance Traits in Camelina, Supporting Large Acreage Production of Low-carbon Intensity Feedstock Oil for the Biofuel Market
Published:
2023-08-02
(Crawled : 12:20)
- globenewswire.com
YTEN
|
$0.252
-7.59%
-8.21%
280K
|
Health Technology
|
-87.67%
|
O:
-3.08%
H:
0.0%
C:
-7.73%
test
positive
bioscience
results
market
Bristol Myers Squibb Receives Positive CHMP Opinion Recommending Approval for Opdivo (nivolumab) as an Adjuvant Treatment for Patients with Completely Resected Stage IIB or IIC Melanoma
Published:
2023-07-21
(Crawled : 12:20)
- biospace.com/
BMY
|
$48.93
1.3%
0.0%
10M
|
Health Technology
|
-24.26%
|
O:
0.19%
H:
1.41%
C:
1.24%
melanoma
chmp
opdivo
approval
positive
treatment
Grifols Achieves Positive Topline Results From Phase 4 Study of XEMBIFY® (immune globulin subcutaneous human-klhw) Evaluating Biweekly Dosing Option for Patients
Published:
2023-07-20
(Crawled : 12:20)
- globenewswire.com
GRFS
|
News
|
$6.29
-3.82%
-3.97%
1.2M
|
Health Technology
|
-37.6%
|
O:
-2.19%
H:
2.83%
C:
2.54%
xembify
positive
topline
results
study
Journey Medical Corporation Announces Positive Topline Results from its Two Phase 3 Clinical Trials (MVOR-1 and MVOR-2) Evaluating DFD-29 for the Treatment of Papulopustular Rosacea in Adults
Published:
2023-07-11
(Crawled : 12:20)
- globenewswire.com
DERM
|
$3.45
-3.63%
-3.77%
100K
|
|
33.8%
|
O:
0.35%
H:
4.91%
C:
-17.19%
FBIO
|
$1.765
-2.49%
-2.55%
190K
|
Health Technology
|
206.89%
|
O:
-0.61%
H:
3.47%
C:
-1.77%
dfd-29
corporation
positive
treatment
trials
topline
medical
results
Daré Bioscience Announces Additional Positive Data from Exploratory Phase 2b RESPOND Study of Sildenafil Cream, 3.6% in Women
Published:
2023-07-11
(Crawled : 12:20)
- globenewswire.com
DARE
|
$0.2838
-3.83%
-3.98%
550K
|
Health Technology
|
-65.13%
|
O:
-0.62%
H:
5.25%
C:
2.4%
positive
bioscience
women
study
Purple Biotech Reports Positive Results of CM24 Dose Escalation in Advanced Pancreatic Cancer Patients
Published:
2023-07-11
(Crawled : 12:20)
- globenewswire.com
PPBT
|
$0.456
-1.09%
-1.1%
52K
|
Manufacturing
|
-71.14%
|
O:
-6.04%
H:
6.43%
C:
-1.79%
cm24
biotech
positive
cancer
pancreatic
purple
results
SELLAS Life Sciences Reports Positive Data in Completed Phase 1 Study of Galinpepimut-S Combined with Opdivo® in Advanced Malignant Pleural Mesothelioma
Published:
2023-06-28
(Crawled : 12:20)
- globenewswire.com
SLS
|
$1.525
0.33%
0.33%
1.8M
|
Health Technology
|
-14.02%
|
O:
-0.61%
H:
3.68%
C:
-0.61%
opdivo
life
positive
sciences
study
89bio Publishes Positive Results from Phase 2 ENTRIGUE Trial of Pegozafermin in Patients with Severe Hypertriglyceridemia (SHTG) in Nature Medicine
Published:
2023-06-24
(Crawled : 12:20)
- globenewswire.com
ETNB
|
$9.08
2.25%
2.2%
1M
|
Health Technology
|
Email alert
Add to watchlist
positive
trial
results
phase 2
Horizon Therapeutics plc Announces Positive Topline Data from Phase 3 Clinical Trial (OPTIC-J) in Japan Evaluating TEPEZZA® (teprotumumab-trbw) for the Treatment of Active Thyroid Eye Disease (TED)
Published:
2023-06-22
(Crawled : 12:20)
- biospace.com/
HZNP
|
$116.3
0.03%
29M
|
Health Technology
|
14.47%
|
O:
-0.25%
H:
0.75%
C:
0.04%
tepezza
disease
active
japan
positive
treatment
thyroid
topline
eye
trial
therapeutics
SAB Biotherapeutics Presents Positive IND-Enabling GLP Toxicology Study for SAB-142, a Novel Immunotherapeutic for Type 1 Diabetes at FOCIS 2023
Published:
2023-06-21
(Crawled : 12:20)
- globenewswire.com
SABS
|
$4.46
0.22%
890
|
|
422.73%
|
O:
-1.14%
H:
1.15%
C:
-1.25%
sab-142
positive
diabetes
study
Journey Medical Corporation Announces Positive Topline Data from Phase 1 Clinical Trial Assessing the Impact of DFD-29 (Minocycline Hydrochloride Modified Release Capsules, 40 mg) on Microbial Flora of Healthy Adult Subjects
Published:
2023-06-13
(Crawled : 12:20)
- globenewswire.com
DERM
|
$3.45
-3.63%
-3.77%
100K
|
|
127.54%
|
O:
8.98%
H:
32.97%
C:
12.09%
FBIO
|
$1.765
-2.49%
-2.55%
190K
|
Health Technology
|
198.31%
|
O:
-0.85%
H:
4.27%
C:
1.54%
dfd-29
corporation
positive
topline
impact
medical
trial
Daré Bioscience Announces Positive Topline Data from the Exploratory Phase 2b RESPOND Study of Sildenafil Cream, 3.6% in Women with Female Sexual Arousal Disorder
Published:
2023-06-05
(Crawled : 12:20)
- globenewswire.com
DARE
|
$0.2838
-3.83%
-3.98%
550K
|
Health Technology
|
-70.59%
|
O:
0.0%
H:
0.0%
C:
-2.02%
positive
bioscience
women
topline
study
Catalyst Pharmaceuticals Reports Positive Momentum in Second Quarter 2023
Published:
2023-06-01
(Crawled : 12:20)
- globenewswire.com
CPRX
|
$15.12
-1.43%
-1.46%
7.4M
|
Health Technology
|
34.55%
|
O:
-0.87%
H:
1.75%
C:
1.66%
momentum
positive
pharmaceuticals
Rocket Pharmaceuticals Presents Positive Data from LV Hematology and AAV Cardiovascular Gene Therapy Programs at the 26th Annual Meeting of the American Society of Gene and Cell Therapy (ASGCT)
Published:
2023-05-19
(Crawled : 12:20)
- biospace.com/
RCKT
M
|
$22.82
-2.81%
-2.89%
960K
|
Health Technology
|
10.29%
|
O:
2.35%
H:
1.24%
C:
0.6%
positive
cell
pharmaceuticals
meeting
cardiovascular
therapy
← Previous
1
2
3
4
5
Next →
Gainers vs Losers
67%
33%
Top 10 Gainers
AGBA
|
News
|
$1.26
215.0%
68.25%
130M
|
Finance
EGOX
|
$0.0515
43.06%
30.1%
330M
|
OLB
4
|
$0.33
-14.95%
25.53%
840K
|
Technology Services
NVFY
|
$2.77
31.28%
23.83%
33M
|
Consumer Durables
ZCMD
|
$1.87
28.97%
22.46%
31M
|
Commercial Services
RCON
|
$0.1112
13.01%
21.28%
1.7M
|
Distribution Services
INSG
|
$3.03
25.21%
20.13%
330K
|
Electronic Technology
GCTK
|
$0.8191
22.25%
18.2%
190K
|
Manufacturing
WLGS
|
$0.59
18.0%
17.9%
2.3M
|
ASNS
|
$0.828
21.75%
17.86%
18K
|
Your saved searches
Save your searches and get alerts when important news are released.